A Comprehensive Metabolomics Analysis of Fecal Samples from Advanced Adenoma and Colorectal Cancer Patients

Accurate diagnosis of colorectal cancer (CRC) still relies on invasive colonoscopy. Noninvasive methods are less sensitive in detecting the disease, particularly in the early stage. In the current work, a metabolomics analysis of fecal samples was carried out by ultra-high-performance liquid chromat...

Full description

Bibliographic Details
Main Authors: Oiana Telleria, Oihane E. Alboniga, Marc Clos-Garcia, Beatriz Nafría-Jimenez, Joaquin Cubiella, Luis Bujanda, Juan Manuel Falcón-Pérez
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Metabolites
Subjects:
Online Access:https://www.mdpi.com/2218-1989/12/6/550
_version_ 1827658514117427200
author Oiana Telleria
Oihane E. Alboniga
Marc Clos-Garcia
Beatriz Nafría-Jimenez
Joaquin Cubiella
Luis Bujanda
Juan Manuel Falcón-Pérez
author_facet Oiana Telleria
Oihane E. Alboniga
Marc Clos-Garcia
Beatriz Nafría-Jimenez
Joaquin Cubiella
Luis Bujanda
Juan Manuel Falcón-Pérez
author_sort Oiana Telleria
collection DOAJ
description Accurate diagnosis of colorectal cancer (CRC) still relies on invasive colonoscopy. Noninvasive methods are less sensitive in detecting the disease, particularly in the early stage. In the current work, a metabolomics analysis of fecal samples was carried out by ultra-high-performance liquid chromatography–tandem mass spectroscopy (UPLC-MS/MS). A total of 1380 metabolites were analyzed in a cohort of 120 fecal samples from patients with normal colonoscopy, advanced adenoma (AA) and CRC. Multivariate analysis revealed that metabolic profiles of CRC and AA patients were similar and could be clearly separated from control individuals. Among the 25 significant metabolites, sphingomyelins (SM), lactosylceramides (LacCer), secondary bile acids, polypeptides, formiminoglutamate, heme and cytidine-containing pyrimidines were found to be dysregulated in CRC patients. Supervised random forest (RF) and logistic regression algorithms were employed to build a CRC accurate predicted model consisting of the combination of hemoglobin (Hgb) and bilirubin E,E, lactosyl-N-palmitoyl-sphingosine, glycocholenate sulfate and STLVT with an accuracy, sensitivity and specificity of 91.67% (95% Confidence Interval (CI) 0.7753–0.9825), 0.7 and 1, respectively.
first_indexed 2024-03-09T23:03:48Z
format Article
id doaj.art-3dc9a26a23c046dea4ccb3a0669a6e04
institution Directory Open Access Journal
issn 2218-1989
language English
last_indexed 2024-03-09T23:03:48Z
publishDate 2022-06-01
publisher MDPI AG
record_format Article
series Metabolites
spelling doaj.art-3dc9a26a23c046dea4ccb3a0669a6e042023-11-23T17:56:31ZengMDPI AGMetabolites2218-19892022-06-0112655010.3390/metabo12060550A Comprehensive Metabolomics Analysis of Fecal Samples from Advanced Adenoma and Colorectal Cancer PatientsOiana Telleria0Oihane E. Alboniga1Marc Clos-Garcia2Beatriz Nafría-Jimenez3Joaquin Cubiella4Luis Bujanda5Juan Manuel Falcón-Pérez6Exosomes Laboratory, CIC bioGUNE-BRTA, CIBERehd, Bizkaia Technology Park, 48160 Bilbao, SpainMetabolomics Platform, CIC bioGUNE-BRTA, CIBERehd, Bizkaia Technology Park, 48160 Bilbao, SpainLEITAT Technological Center, C/de la Innovació, 2, 08225 Terrassa, SpainOsakidetza Basque Health Service, Donostialdea Integrated Health Organisation, Clinical Biochemistry Department, 20014 San Sebastian, SpainDepartment of Gastroenterology, Complexo Hospitalario Universitario de Ourense, Instituto de Investigación Sanitaria Galicia Sur, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), 32005 Ourense, SpainDepartment of Gastroenterology, Hospital Donostia/Instituto Biodonostia, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Universidad del País Vasco (UPV/EHU), 20014 San Sebastián, SpainExosomes Laboratory, CIC bioGUNE-BRTA, CIBERehd, Bizkaia Technology Park, 48160 Bilbao, SpainAccurate diagnosis of colorectal cancer (CRC) still relies on invasive colonoscopy. Noninvasive methods are less sensitive in detecting the disease, particularly in the early stage. In the current work, a metabolomics analysis of fecal samples was carried out by ultra-high-performance liquid chromatography–tandem mass spectroscopy (UPLC-MS/MS). A total of 1380 metabolites were analyzed in a cohort of 120 fecal samples from patients with normal colonoscopy, advanced adenoma (AA) and CRC. Multivariate analysis revealed that metabolic profiles of CRC and AA patients were similar and could be clearly separated from control individuals. Among the 25 significant metabolites, sphingomyelins (SM), lactosylceramides (LacCer), secondary bile acids, polypeptides, formiminoglutamate, heme and cytidine-containing pyrimidines were found to be dysregulated in CRC patients. Supervised random forest (RF) and logistic regression algorithms were employed to build a CRC accurate predicted model consisting of the combination of hemoglobin (Hgb) and bilirubin E,E, lactosyl-N-palmitoyl-sphingosine, glycocholenate sulfate and STLVT with an accuracy, sensitivity and specificity of 91.67% (95% Confidence Interval (CI) 0.7753–0.9825), 0.7 and 1, respectively.https://www.mdpi.com/2218-1989/12/6/550untargeted metabolomicscolorectal cancerfaecal samplesbiomarkers
spellingShingle Oiana Telleria
Oihane E. Alboniga
Marc Clos-Garcia
Beatriz Nafría-Jimenez
Joaquin Cubiella
Luis Bujanda
Juan Manuel Falcón-Pérez
A Comprehensive Metabolomics Analysis of Fecal Samples from Advanced Adenoma and Colorectal Cancer Patients
Metabolites
untargeted metabolomics
colorectal cancer
faecal samples
biomarkers
title A Comprehensive Metabolomics Analysis of Fecal Samples from Advanced Adenoma and Colorectal Cancer Patients
title_full A Comprehensive Metabolomics Analysis of Fecal Samples from Advanced Adenoma and Colorectal Cancer Patients
title_fullStr A Comprehensive Metabolomics Analysis of Fecal Samples from Advanced Adenoma and Colorectal Cancer Patients
title_full_unstemmed A Comprehensive Metabolomics Analysis of Fecal Samples from Advanced Adenoma and Colorectal Cancer Patients
title_short A Comprehensive Metabolomics Analysis of Fecal Samples from Advanced Adenoma and Colorectal Cancer Patients
title_sort comprehensive metabolomics analysis of fecal samples from advanced adenoma and colorectal cancer patients
topic untargeted metabolomics
colorectal cancer
faecal samples
biomarkers
url https://www.mdpi.com/2218-1989/12/6/550
work_keys_str_mv AT oianatelleria acomprehensivemetabolomicsanalysisoffecalsamplesfromadvancedadenomaandcolorectalcancerpatients
AT oihaneealboniga acomprehensivemetabolomicsanalysisoffecalsamplesfromadvancedadenomaandcolorectalcancerpatients
AT marcclosgarcia acomprehensivemetabolomicsanalysisoffecalsamplesfromadvancedadenomaandcolorectalcancerpatients
AT beatriznafriajimenez acomprehensivemetabolomicsanalysisoffecalsamplesfromadvancedadenomaandcolorectalcancerpatients
AT joaquincubiella acomprehensivemetabolomicsanalysisoffecalsamplesfromadvancedadenomaandcolorectalcancerpatients
AT luisbujanda acomprehensivemetabolomicsanalysisoffecalsamplesfromadvancedadenomaandcolorectalcancerpatients
AT juanmanuelfalconperez acomprehensivemetabolomicsanalysisoffecalsamplesfromadvancedadenomaandcolorectalcancerpatients
AT oianatelleria comprehensivemetabolomicsanalysisoffecalsamplesfromadvancedadenomaandcolorectalcancerpatients
AT oihaneealboniga comprehensivemetabolomicsanalysisoffecalsamplesfromadvancedadenomaandcolorectalcancerpatients
AT marcclosgarcia comprehensivemetabolomicsanalysisoffecalsamplesfromadvancedadenomaandcolorectalcancerpatients
AT beatriznafriajimenez comprehensivemetabolomicsanalysisoffecalsamplesfromadvancedadenomaandcolorectalcancerpatients
AT joaquincubiella comprehensivemetabolomicsanalysisoffecalsamplesfromadvancedadenomaandcolorectalcancerpatients
AT luisbujanda comprehensivemetabolomicsanalysisoffecalsamplesfromadvancedadenomaandcolorectalcancerpatients
AT juanmanuelfalconperez comprehensivemetabolomicsanalysisoffecalsamplesfromadvancedadenomaandcolorectalcancerpatients